TO

TORII PHARMACEUTICAL CO., LTD.

Develops and markets drugs for renal diseases, skin diseases, HIV, and allergies.

4551 | T

Overview

Corporate Details

ISIN(s):
JP3635800000
LEI:
Country:
Japan
Address:
中央区日本橋本町三丁目4番1号

Description

Torii Pharmaceutical Co., Ltd. is a pharmaceutical company engaged in the development, manufacturing, and marketing of prescription drugs. The company's primary focus is on therapeutic agents for renal diseases and hemodialysis, particularly for chronic kidney disease (CKD). Its portfolio also includes products for skin diseases, HIV, and allergies. Torii Pharmaceutical utilizes strategic partnerships and promotes medical products from its parent company, Japan Tobacco, to provide specialized pharmaceutical solutions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2022-08-01 03:51
四半期報告書-第131期第2四半期(令和4年4月1日-令和4年6月30日)
Japanese ZIP 200.9 KB
2022-04-28 08:04
四半期報告書-第131期第1四半期(令和4年1月1日-令和4年3月31日)
Japanese ZIP 154.9 KB
2022-03-29 08:19
内部統制報告書-第130期(令和3年1月1日-令和3年12月31日)
Japanese ZIP 24.1 KB
2022-03-29 08:17
確認書
Japanese ZIP 9.3 KB
2022-03-29 08:15
有価証券報告書-第130期(令和3年1月1日-令和3年12月31日)
Japanese ZIP 832.6 KB
2021-11-01 01:33
四半期報告書-第130期第3四半期(令和3年7月1日-令和3年9月30日)
Japanese ZIP 161.0 KB
2021-08-02 02:49
四半期報告書-第130期第2四半期(令和3年4月1日-令和3年6月30日)
Japanese ZIP 194.0 KB
2021-04-28 08:28
四半期報告書-第130期第1四半期(令和3年1月1日-令和3年3月31日)
Japanese ZIP 160.1 KB
2021-03-25 05:25
内部統制報告書-第129期(令和2年1月1日-令和2年12月31日)
Japanese ZIP 24.2 KB
2021-03-25 05:20
確認書
Japanese ZIP 9.3 KB
2021-03-25 05:13
有価証券報告書-第129期(令和2年1月1日-令和2年12月31日)
Japanese ZIP 786.7 KB
2020-11-02 02:39
四半期報告書-第129期第3四半期(令和2年7月1日-令和2年9月30日)
Japanese ZIP 160.8 KB
2020-08-03 02:45
四半期報告書-第129期第2四半期(令和2年4月1日-令和2年6月30日)
Japanese ZIP 202.9 KB
2020-04-30 08:04
四半期報告書-第129期第1四半期(令和2年1月1日-令和2年3月31日)
Japanese ZIP 158.7 KB
2020-03-26 05:38
有価証券報告書-第128期(平成31年1月1日-令和1年12月31日)
Japanese ZIP 755.1 KB

Automate Your Workflow. Get a real-time feed of all TORII PHARMACEUTICAL CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for TORII PHARMACEUTICAL CO., LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for TORII PHARMACEUTICAL CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.